S Akhondzadeh

Summary

Affiliation: Tehran University of Medical Sciences
Country: Iran

Publications

  1. ncbi Diazoxide in the treatment of schizophrenia: novel application of potassium channel openers in the treatment of schizophrenia
    S Akhondzadeh
    Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran
    J Clin Pharm Ther 27:453-9. 2002
  2. ncbi Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial
    M R Mohammadi
    Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran
    J Clin Pharm Ther 29:139-44. 2004
  3. ncbi Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial
    H Amini
    Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran
    J Clin Pharm Ther 30:133-8. 2005
  4. ncbi Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial
    S Akhondzadeh
    Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences and Institute of Medicinal Plants, Iranian Academic Centre for Education, Culture and Research, Tehran, Iran
    J Clin Pharm Ther 28:53-9. 2003
  5. ncbi Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial
    S Akhondzadeh
    Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, South Kargar Avenue, Tehran 13334, Iran
    J Clin Pharm Ther 26:369-73. 2001
  6. pmc Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial
    S Akhondzadeh
    Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran
    J Neurol Neurosurg Psychiatry 74:863-6. 2003
  7. ncbi Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal
    S Akhondzadeh
    Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, South Kargar Avenue, Tehran, Iran
    J Clin Pharm Ther 25:347-53. 2000
  8. ncbi Cyproheptadine in treatment of chronic schizophrenia: a double-blind, placebo-controlled study
    S Akhondzadeh
    Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Iran
    J Clin Pharm Ther 24:49-52. 1999
  9. ncbi Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions
    S Akhondzadeh
    Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, South Kargar Avenue, Tehran 13334, Iran
    J Clin Pharm Ther 25:131-7. 2000
  10. doi Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial
    S Akhondzadeh
    Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran Institute of Medicinal Plants ACECR, Department of Neurology, Tehran, Iran
    J Clin Pharm Ther 35:581-8. 2010

Collaborators

  • M Abdollahi
  • M Sadeghi
  • H Amini
  • L Kouti
  • M Agha-Hosseini
  • L Kashani
  • A A Noorbala
  • M R Mohammadi
  • S S Gudarzi
  • P Ghaeli
  • M Noroozian
  • S Mousavi
  • M A Faramarzi
  • M R Javadi
  • S A Ahmadi-Abhari
  • A Aleyaseen
  • H Rahmanpour
  • A R Zarrinara
  • A Ghoreishi
  • N Tahmacebi-Pour
  • A H Jamshidi
  • S Ohadinia
  • E S Izadian
  • M Yasamy
  • S M Assadi
  • A Kamlipour
  • Z M Farzanehgan
  • O L Shabestari

Detail Information

Publications21

  1. ncbi Diazoxide in the treatment of schizophrenia: novel application of potassium channel openers in the treatment of schizophrenia
    S Akhondzadeh
    Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran
    J Clin Pharm Ther 27:453-9. 2002
    ..The purpose of the present investigation was to assess the efficacy of diazoxide, as an adjuvant agent in the treatment of schizophrenia...
  2. ncbi Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial
    M R Mohammadi
    Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran
    J Clin Pharm Ther 29:139-44. 2004
    ..In addition, a tolerable side-effect profile is one of the advantages of theophylline in the treatment of ADHD. Nevertheless, our study is small and our results would need to be confirmed in a larger study...
  3. ncbi Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial
    H Amini
    Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran
    J Clin Pharm Ther 30:133-8. 2005
    ..The aim of this study was to compare the efficacy and tolerability of mirtazapine and fluoxetine treatment in a sample population consisting of Iranian patients suffering major depressive disorder...
  4. ncbi Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial
    S Akhondzadeh
    Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences and Institute of Medicinal Plants, Iranian Academic Centre for Education, Culture and Research, Tehran, Iran
    J Clin Pharm Ther 28:53-9. 2003
    ..The objective of this study was to assess the efficacy and safety of Salvia officinalis extract using a fixed dose (60 drops/day), in patients with mild to moderate Alzheimer's disease, over a 4-month period...
  5. ncbi Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial
    S Akhondzadeh
    Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, South Kargar Avenue, Tehran 13334, Iran
    J Clin Pharm Ther 26:369-73. 2001
    ..We present the results of a double-blind randomized controlled trial of clonidine plus passiflora extract vs. clonidine plus placebo in the outpatient detoxification of 65 opiates addicts...
  6. pmc Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial
    S Akhondzadeh
    Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran
    J Neurol Neurosurg Psychiatry 74:863-6. 2003
    ..To assess the efficacy and safety of Melissa officinalis extract using a fixed dose (60 drops/day) in patients with mild to moderate Alzheimer's disease...
  7. ncbi Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal
    S Akhondzadeh
    Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, South Kargar Avenue, Tehran, Iran
    J Clin Pharm Ther 25:347-53. 2000
    ..However, accumulating evidence in rats shows the efficacy of the GABAB receptor agonist, baclofen, in reducing alcohol intake and self-administration of cocaine...
  8. ncbi Cyproheptadine in treatment of chronic schizophrenia: a double-blind, placebo-controlled study
    S Akhondzadeh
    Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Iran
    J Clin Pharm Ther 24:49-52. 1999
    ..We undertook a trial to investigate whether the combination of haloperidol with cyproheptadine, a relatively safe serotonin-blocking agent was more effective than haloperidol alone...
  9. ncbi Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions
    S Akhondzadeh
    Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, South Kargar Avenue, Tehran 13334, Iran
    J Clin Pharm Ther 25:131-7. 2000
    ..We undertook a pilot trial to investigate whether the combination of haloperidol with dipyridamole, an uptake inhibitor of adenosine, was more effective than haloperidol alone...
  10. doi Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial
    S Akhondzadeh
    Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran Institute of Medicinal Plants ACECR, Department of Neurology, Tehran, Iran
    J Clin Pharm Ther 35:581-8. 2010
    ..Crocus sativus (saffron) may inhibit the aggregation and deposition of amyloid β in the human brain and may therefore be useful in Alzheimer's disease (AD)...
  11. ncbi Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam
    S Akhondzadeh
    Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, South Kargar Avenue, Tehran, Iran
    J Clin Pharm Ther 26:363-7. 2001
    ..Passionflower (Passiflora incarnata) is a folk remedy for anxiety. A double-blind randomized trial compared the efficacy of Passiflora incarnata extract with oxazepam in the treatment of generalized anxiety disorder...
  12. doi Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial
    M Agha-Hosseini
    Infertility Center of Dr Shariati Hospital, Vali Asr Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran
    BJOG 115:515-9. 2008
    ..The aim of this double-blind and placebo-controlled trial was to investigate whether saffron (stigma of Crocus sativus L.) could relieve symptoms of premenstrual syndrome (PMS)...
  13. ncbi Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial
    S Akhondzadeh
    Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, South Kargar Street, Tehran, Iran
    J Clin Pharm Ther 29:145-50. 2004
    ..In this 8-week double-blind, placebo-controlled trial, we assessed the effects of cyproheptadine plus haloperidol in the treatment of autistic disorder...
  14. ncbi Nitric oxide and peroxynitrite serum levels in Parkinson's disease: correlation of oxidative stress and the severity of the disease
    L Kouti
    Department of Clinical Pharmacy, Pharmaceutical Sciences Research Centre, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
    Eur Rev Med Pharmacol Sci 17:964-70. 2013
    ..The relationship of serum levels of these oxidants with the severity of the disease [evaluated by the Unified Parkinson's Disease Rating Scale (UPDRS)] is not established...
  15. ncbi Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression
    S Akhondzadeh
    Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran
    J Clin Pharm Ther 28:379-84. 2003
    ..The objective of this double-blind study was to compare the efficacy and safety of fluoxetine and nortriptyline in patients with moderate to severe major depression...
  16. ncbi Is it time to have another look at lithium maintenance therapy in bipolar disorder?
    S Akhondzadeh
    Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Iran
    Prog Neuropsychopharmacol Biol Psychiatry 23:1011-7. 1999
    ..In addition, the percentages of manic episode after lithium therapy were much greater than before that. 4. The results indicate that it is worth re-examining the efficacy of lithium in bipolar disorders...
  17. ncbi Cyproheptadine in treatment of autism
    S S Gudarzi
    Department of Psychiatry, Shaheed Beheshti University of Medical Sciences, 16179, Tehran, Iran
    Eur Psychiatry 17:230-1. 2002
  18. ncbi Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized controlled trial
    S A Ahmadi-Abhari
    Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, South Kargar Avenue, Tehran 13334, Iran
    J Clin Pharm Ther 26:67-71. 2001
    ..CONCLUSION: We conclude that, the low incidence of hypotension with baclofen suggests that the drug may be suitable for outpatient ambulatory treatment of withdrawal from opiates...
  19. ncbi Prevention of muscimol-induced long-term depression by brain-derived neurotrophic factor
    S Akhondzadeh
    Institute of Medicinal Plants, Tehran, Iran
    Prog Neuropsychopharmacol Biol Psychiatry 23:1215-26. 1999
    ....
  20. ncbi Hippocampal synaptic plasticity and cognition
    S Akhondzadeh
    Department of Pharmacology and Therapeutics, Institute of Medicinal Plants, Tehran, Iran
    J Clin Pharm Ther 24:241-8. 1999
    ..Therefore, the possibility of the discovery and development of compounds that, by modulating hippocampal synaptic plasticity, would be useful for the management of dementia and amnesia...
  21. ncbi Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial
    A A Noorbala
    Psychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, South Kargar Avenue, Tehran 13337, Iran
    J Ethnopharmacol 97:281-4. 2005
    ..The results of this study indicate the efficacy of Crocus sativus in the treatment of mild to moderate depression. A large-scale trial is justified...